Evaluation of an offline, artificial intelligence system for referable glaucoma screening using a smartphone-based fundus camera: a prospective study.

Autor: Rao DP; Remidio Innovative Solutions Inc, Glen Allen, VA, USA. drdivya@remidio.com., Shroff S; Narayana Nethralaya Eye Hospital, Glaucoma Services, Bangalore, India., Savoy FM; Medios Technologies Pte Ltd, Singapore, Singapore., S S; Narayana Nethralaya Eye Hospital, Glaucoma Services, Bangalore, India., Hsu CK; Medios Technologies Pte Ltd, Singapore, Singapore., Negiloni K; Remidio Innovative Solutions Pvt Ltd, Bengaluru, India., Pradhan ZS; Narayana Nethralaya Eye Hospital, Glaucoma Services, Bangalore, India., P V J; Narayana Nethralaya Eye Hospital, Glaucoma Services, Bangalore, India., Sivaraman A; Remidio Innovative Solutions Pvt Ltd, Bengaluru, India., Rao HL; Narayana Nethralaya Eye Hospital, Glaucoma Services, Bangalore, India.
Jazyk: angličtina
Zdroj: Eye (London, England) [Eye (Lond)] 2024 Apr; Vol. 38 (6), pp. 1104-1111. Date of Electronic Publication: 2023 Dec 13.
DOI: 10.1038/s41433-023-02826-z
Abstrakt: Background/objectives: An affordable and scalable screening model is critical for undetected glaucoma. The study evaluated the performance of an offline, smartphone-based AI system for the detection of referable glaucoma against two benchmarks: specialist diagnosis following full glaucoma workup and consensus image grading.
Subjects/methods: This prospective study (tertiary glaucoma centre, India) included 243 subjects with varying severity of glaucoma and control group without glaucoma. Disc-centred images were captured using a validated smartphone-based fundus camera analysed by the AI system and graded by specialists. Diagnostic ability of the AI in detecting referable Glaucoma (Confirmed glaucoma) and no referable Glaucoma (Suspects and No glaucoma) when compared to a final diagnosis (comprehensive glaucoma workup) and majority grading (image grading) by Glaucoma specialists (pre-defined criteria) were evaluated.
Results: The AI system demonstrated a sensitivity and specificity of 93.7% (95% CI: 87.6-96.9%) and 85.6% (95% CI:78.6-90.6%), respectively, in the detection of referable glaucoma when compared against final diagnosis following full glaucoma workup. True negative rate in definite non-glaucoma cases was 94.7% (95% CI: 87.2-97.9%). Amongst the false negatives were 4 early and 3 moderate glaucoma. When the same set of images provided to the AI was also provided to the specialists for image grading, specialists detected 60% (67/111) of true glaucoma cases versus a detection rate of 94% (104/111) by the AI.
Conclusion: The AI tool showed robust performance when compared against a stringent benchmark. It had modest over-referral of normal subjects despite being challenged with fundus images alone. The next step involves a population-level assessment.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: